Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200

K-Number: K010283 · 2001-04-26

ApplicantTheragenics Corp.
Decision Date2001-04-26
Product CodeKXK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200 is the device name listed in this FDA 510(k) record. The listed applicant is Theragenics Corp.. It received FDA 510(k) clearance on 2001-04-26 under 510(k) number K010283. The device is classified under product code KXK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200?

THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200 is a medical device that received FDA 510(k) clearance on 2001-04-26. The listed applicant is Theragenics Corp.. The 510(k) number is K010283.

When did THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200 receive FDA 510(k) clearance?

THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200 received FDA 510(k) clearance on 2001-04-26, under 510(k) number K010283.

Who is the listed applicant for THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200?

The FDA 510(k) record lists Theragenics Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200?

The FDA product code for THERASEED(R) PALLADIUM-103 IMPLANT; MODEL 200 is KXK.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Theragenics Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K103319I-SEEDK072296POIINT OF CARE STRANDING SYSTEM, MODE 1004-00K043596THERALOAD CUSTOM LOADED NEEDLES, MODELS 200 AND 125.S06K874787MODIFIED PALLADIUM SEED MODEL 100

Related Devices (Code: KXK)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252296OncoPatchOncopatch, Inc.K242818IsoSphereIsoaid, LLCK223465RadianceTx Radionuclide Brachytherapy SourceRadiance Therapeutics, Inc.K221539GammaTileGt Medical TechnologiesK202267Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge NeedlesIsoray Medical, Inc.K193602LV Liberty Vision Model 1 90Yttrium Brachytherapy SourceLv Liberty Vision Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑